$ALVR investors, if you follow us, you already know about it.
This info hits different after the news. Check it out: https://11th.com/cases/allovir-investor-settlement
If you missed the deadline, don’t miss this update. This is probably the most useful info you’ve read in years about $ALVR — how you can actually recover something: https://11th.com/cases/allovir-investor-settlement
$ALVR has agreed to settle with investors over claims that it misled them about the effectiveness and approval prospects of its lead product, posoleucel.
Who’s eligible?
Anyone who purchased $ALVR shares between January 11, 2023 and December 21, 2023.
Do I need to sell my shares to qualify?
No — you are eligible whether you sold your shares or still hold them.
How much is the payout?
The payout per share is $0.03 — but normally only ~25% of eligible investors file, the effective payout could increase to $0.12.
Can I still file?
Yes — late claims are currently being considered for compensation, subject to approval.
When do payouts happen?
Typically within 8–12 months after court approval of the settlement.
To file your claim: https://11th.com/cases/allovir-investor-settlement
Imagine buying $ALVR at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back.
To all $ALVR investors out there, we’ve got some important news for you: https://11th.com/cases/allovir-investor-settlement
$ALVR is now accepting claims for a $1M settlement it is paying to investors over claims that it misled them about the effectiveness of its lead product, Posoleucel.
Even if you missed the deadline, if you bought $ALVR between January 11, 2023 and December 21, 2023, you still can file for payment here: https://11th.com/cases/allovir-investor-settlement
When we see a stock like this, we know how many damaged investors are out there.
Believe it or not, there’s some good news.
$ALVR investors — you might be surprised, but you actually have a chance to recover your losses. Don’t miss it: https://11th.com/cases/allovir-investor-settlement
$ALVR has agreed to settle with investors over claims that it misled them about the effectiveness of its lead product, posoleucel.
Who’s eligible?
Anyone who purchased $ALVR shares between January 11, 2023 and December 21, 2023.
Do I need to sell my shares to qualify?
No — you are eligible whether you sold your shares or still hold them.
How much is the payout?
The payout per share is $0.03 — but if only ~25% of eligible investors file, the effective payout could increase to $0.12.
Can I still file?
Yes — claims are currently being accepted.
When do payouts happen?
Typically within 8–12 months after court approval of the settlement.
To file your claim: https://11th.com/cases/allovir-investor-settlement
Don't forget that there is also an important settlement to watch for $ALVR.
We have every detail, including how investors can get paid.
https://11th.com/cases/allovir-investor-settlement
$ALVR investors — there’s no hidden secret here. Just one thing you really need to know.
Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more.
https://11th.com/cases/allovir-investor-settlement
$ALVR investors — there’s no hidden secret here. Just one thing you really need to know.
Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more. #AlloVir #ALVR
https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=11182025
$ALVR is now accepting claims for a $1M settlement it is paying to investors over claims that it misled them about the effectiveness of its lead product, Posoleucel.
Even if you missed the deadline, if you bought $ALVR between January 11, 2023, and December 21, 2023, you still can file for payment here: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=11042025
$ALVR has agreed to a $1M settlement to resolve claims that it misled investors about the effectiveness and prospects of its lead product, Posoleucel.
Who’s eligible?
Anyone who purchased $ALVR shares between January 11, 2023, and December 21, 2023.
Do I need to sell my shares to qualify?
No — you are eligible whether you sold your shares or still hold them.
How much is the payout?
The payout per share is $0.03 — but if only ~25% of eligible investors file, the effective payout could increase to $0.12.
Can I still file?
Yes — claims are currently being accepted, including late claims (claim deadline pending court approval).
When do payouts happen?
Typically within 8–12 months after court approval of the settlement.
To file your claim: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=10222025_1
